|
⚲
|
| Keyboard |
| Kantesaria Devang
✚
|
|
|---|---|
| CIK # | 0001632466 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001632466] | |
| 4 | [0001632466] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Rocket Pharmaceuticals Inc | |
| Devon Park Associates LLC | |
| Kantesaria Devang | |
| Devon Park Associates LP |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Rocket Pharmaceuticals Inc ITEK
Common Stock
|
2015-07-14 | Option exercise | 9,857 | $4.34 | 42,779 |
|
Rocket Pharmaceuticals Inc ITEK
Stock Options (Right to Buy) · derivative
|
2015-07-14 | Option exercise | 9,857 | $0.00 | |
|
Rocket Pharmaceuticals Inc ITEK
Common Stock
|
2015-02-23 | Buy | 814,166 | $6.00 | 4,884,996 |
|
Rocket Pharmaceuticals Inc ITEK
Common Stock
|
2015-02-23 | Conversion | 2,323,610 | ||
|
Rocket Pharmaceuticals Inc ITEK
Common Stock
|
2015-02-23 | Conversion | 105,933 | ||
|
Rocket Pharmaceuticals Inc ITEK
Convertible Promissory Notes · derivative
|
2015-02-23 | Conversion | 626,942.90 | ||
|
Rocket Pharmaceuticals Inc ITEK
Series AA Convertible Preferred Stock · derivative
|
2015-02-23 | Conversion | 7,432,720 |